Researchers have successfully created living cells from dead bacteria by transplanting a fully synthetic genome, a breakthrough that could accelerate progress in synthetic biology. The achievement demonstrates a powerful new method for engineering organisms to perform specific tasks, ranging from sustainable fuel production to pharmaceutical manufacturing.
The Problem with Synthetic Life
Synthetic biology aims to design and build biological systems with novel functions. In 2010, scientists created the first synthetic cell by inserting a synthesized genome into a living bacterium. However, verifying whether the cell truly functioned solely under the synthetic genome’s control proved difficult; bacteria readily absorb external DNA, blurring the lines between natural and engineered traits. This is called horizontal gene transfer, and it complicates the process.
A Novel Approach: First Kill, Then Rebuild
To bypass this issue, researchers at the J. Craig Venter Institute (JCVI) took a drastic step: they killed the host bacterium first. Using mitomycin C, a chemotherapy drug that destroys DNA, they rendered Mycoplasma capricolum cells unable to reproduce, effectively making them “functionally dead.” The team then transplanted a synthetic genome from Mycoplasma mycoides into these lifeless cells. The result? Some cells revived, grew, and divided, confirming they were now governed entirely by the synthetic DNA.
What Does This Mean?
These “zombie cells” represent the first living organisms constructed from non-living components. As JCVI’s John Glass explains, “We take a cell without a genome and it is functionally dead. But by adding a new genome, that cell is resurrected.” The implications extend beyond a technical feat; this method challenges our understanding of the boundary between life and non-life. Kate Adamala of the University of Minnesota notes that traditional hallmarks of life—metabolism and replication—are minimized in these cells, raising questions about what truly defines “living.”
The Future of Synthetic Organisms
The technique is currently limited to Mycoplasma bacteria, but researchers believe it is a proof of concept applicable to more complex organisms, including yeast and E. coli. This could enable faster development of “mini chemical factories” engineered to produce drugs or remediate environmental pollutants. The ability to reliably deliver large synthetic DNA payloads overcomes a major bottleneck in the field.
While biosafety concerns exist (the Mycoplasma species used are goat and cattle pathogens), researchers emphasize that existing lab protocols minimize the risk of accidental release. The work represents a fundamental advance, suggesting that biology operates along a more flexible line between life and death than previously understood.
The creation of ‘zombie cells’ is not just a scientific curiosity; it is a step toward more predictable, controllable synthetic life and a glimpse into the potential for engineered organisms to solve real-world problems.
